Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

GEVELOT S.A.: Weekly report of share buyback September 8, 2022
GEVELOT S.A.: Weekly report of share buyback September 8, 2022
GEVELOT S.A.: Weekly report of share buyback September 8, 2022
PATRIMOINE ET COMMERCE: 2022 HALF-YEAR RESULTS
PATRIMOINE ET COMMERCE: 2022 HALF-YEAR RESULTS
PATRIMOINE ET COMMERCE: 2022 HALF-YEAR RESULTS
NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer


Regulatory News:



NANOBIOTIX (Euronext: NANO – Nasdaq: NBTX), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with

Positive Readouts for Transgene’s Clinical Stage Candidates Generated by its Two Innovative Platforms, with Further Clinical Data Expected in the Second Half of 2022: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Positive Readouts for Transgene’s Clinical Stage Candidates Generated by its Two Innovative Platforms, with Further Clinical Data Expected in the Second Half of 2022


Regulatory News:



Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today publishes its financial results for

Thanks to a new social impact investment, REALITES is now offsetting its entire carbon footprint
Thanks to a new social impact investment, REALITES is now offsetting its entire carbon footprint
Thanks to a new social impact investment, REALITES is now offsetting its entire carbon footprint
NANOBIOTIX Co-Founder and CEO Laurent Levy Named to 2022 PharmaVoice 100 List of Most Inspiring People in Life Sciences: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
NANOBIOTIX Co-Founder and CEO Laurent Levy Named to 2022 PharmaVoice 100 List of Most Inspiring People in Life Sciences


Regulatory News:



NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’) (Paris:NANO) (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering physics-based approaches to

DGAP-News: Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology
DGAP-News: Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology
DGAP-News: Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology
DGAP-News: Abivax publishes a prospectus in the context of its capital increase
DGAP-News: Abivax publishes a prospectus in the context of its capital increase
DGAP-News: Abivax publishes a prospectus in the context of its capital increase
Verimatrix präsentiert bahnbrechende Cybersicherheitstechnologie bei IBC Conference: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix präsentiert bahnbrechende Cybersicherheitstechnologie bei IBC Conference


Regulatorische Nachrichten:



Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass er seine leistungsstarken

DGAP-News: ABIVAX: Abivax announces successful oversubscribed EUR 49.2M cross-over financing with top-tier US and European Biotech investors
DGAP-News: ABIVAX: Abivax announces successful oversubscribed EUR 49.2M cross-over financing with top-tier US and European Biotech investors
DGAP-News: ABIVAX: Abivax announces successful oversubscribed EUR 49.2M cross-over financing with top-tier US and European Biotech investors
Verimatrix to Showcase Game-Changing Cybersecurity Technology at IBC Conference: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix to Showcase Game-Changing Cybersecurity Technology at IBC Conference


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced it will highlight its powerful content

GEVELOT S.A.: Weekly report of share buyback September 1, 2022
GEVELOT S.A.: Weekly report of share buyback September 1, 2022
GEVELOT S.A.: Weekly report of share buyback September 1, 2022
Nanobiotix to Present During the H.C. Wainwright Global Investment Conference in September 2022: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix to Present During the H.C. Wainwright Global Investment Conference in September 2022


Regulatory News:



NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’) (Paris:NANO) (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering physics-based approaches to

Transgene Announces Upcoming Investor Meetings: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene Announces Upcoming Investor Meetings


Regulatory News:



Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that Management will

Integration von UniqCast mit Verimatrix Streamkeeper ermöglicht langfristige gemeinsame Cloud-Angebote : https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Integration von UniqCast mit Verimatrix Streamkeeper ermöglicht langfristige gemeinsame Cloud-Angebote


Pflichtmitteilung:



Verimatrix, (Euronext Paris: VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass das in Kroatien

Quantum Genomics (ALQGC): Initiation — A fresh take on cardiovascular medicine
Quantum Genomics (ALQGC): Initiation — A fresh take on cardiovascular medicine
Quantum Genomics (ALQGC): Initiation — A fresh take on cardiovascular medicine
UniqCast Integrates with Verimatrix Streamkeeper, Brings Long-Time Joint Offerings to the Cloud: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
UniqCast Integrates with Verimatrix Streamkeeper, Brings Long-Time Joint Offerings to the Cloud


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Croatia-based UniqCast, an existing

Poxel Announces Positive Results from Phase 2 NASH Trial (DESTINY-1) for PXL065, A Novel, Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces Positive Results from Phase 2 NASH Trial (DESTINY-1) for PXL065, A Novel, Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone


POXEL SA (Euronext : POXEL - FR0012432516), clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including

Telestream integriert Technologie in Verimatrix Streamkeeper Multi-DRM mit Schwerpunkt auf Videoqualitätsüberwachung und -analyse: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Telestream integriert Technologie in Verimatrix Streamkeeper Multi-DRM mit Schwerpunkt auf Videoqualitätsüberwachung und -analyse


Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, und Telestream, ein weltweit führender Anbieter von Lösungen zur Überwachung der

Telestream Integrates with Verimatrix Streamkeeper Multi-DRM, Emphasizes Video Quality Monitoring and Analytics: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Telestream Integrates with Verimatrix Streamkeeper Multi-DRM, Emphasizes Video Quality Monitoring and Analytics


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, and Telestream, a global leader in video quality monitoring

Freelance.com: 2nd quarter 2022 revenue: €201.5 million
Freelance.com: 2nd quarter 2022 revenue: €201.5 million
Freelance.com: 2nd quarter 2022 revenue: €201.5 million
THEOplayer ist neuester mit Verimatrix Streamkeeper Multi-DRM ausgestatteter Videospieler : https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
THEOplayer ist neuester mit Verimatrix Streamkeeper Multi-DRM ausgestatteter Videospieler


Verimatrix, (Euronext Paris: VMX) (Paris: VMX), der führende Anbieter von benutzerorientierten Sicherheitslösungen für die moderne vernetzte Welt, meldete heute, dass THEO Technologies die

THEOplayer Is Latest Video Player to Integrate with Verimatrix Streamkeeper Multi-DRM: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
THEOplayer Is Latest Video Player to Integrate with Verimatrix Streamkeeper Multi-DRM


Regulatory News:



Verimatrix, (Euronext Paris: VMX) (Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced THEO Technologies has completed

GEVELOT S.A.: Weekly report of share buyback August 25, 2022
GEVELOT S.A.: Weekly report of share buyback August 25, 2022
GEVELOT S.A.: Weekly report of share buyback August 25, 2022
Axway ist Leader im aktuellen API Management-Report von Forrester: https://mms.businesswire.com/media/20210427006220/en/800734/5/Axway_logo.jpg
Axway ist Leader im aktuellen API Management-Report von Forrester


Axway, ein führender Anbieter von API-Management- und Integrationssoftware, ist im aktuellen Forrester Wave-Report „API Management Solutions, Q3 2022“, als Leader positioniert worden.



Axway war